Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABT Abbott Laboratories	$84.24 -3.2%	$102.69	$84.08 ▼ $139.06	$146.72B	0.65	11.83 million shs	10.76 million shs
GM General Motors	$78.77 +0.5%	$76.32	$46.81 ▼ $87.62	$71.02B	1.29	7.89 million shs	2.95 million shs
GMM Global Mofy AI	$1.17 -0.8%	$1.31	$0.94 ▼ $3.29	$34.60M	-1.7	134,799 shs	73,358 shs
PFE Pfizer	$25.65 -3.1%	$27.14	$21.97 ▼ $28.75	$146.17B	0.35	42.90 million shs	37.25 million shs
QDEL QuidelOrtho	$10.80 +0.3%	$16.15	$10.21 ▼ $38.99	$735.48M	0.75	1.83 million shs	2.15 million shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABT Abbott Laboratories	+0.79%	-4.20%	-14.58%	-21.58%	-35.06%
GM General Motors	-0.26%	+1.94%	+8.06%	-6.92%	+72.50%
GMM Global Mofy AI	-5.60%	-7.09%	-15.71%	+4.42%	-47.56%
PFE Pfizer	-0.12%	-1.00%	-2.28%	-2.80%	+16.24%
QDEL QuidelOrtho	-1.73%	-12.44%	-28.10%	-62.99%	-58.34%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABT Abbott Laboratories	$84.24 -3.2%	$102.69	$84.08 ▼ $139.06	$146.72B	0.65	11.83 million shs	10.76 million shs
GM General Motors	$78.77 +0.5%	$76.32	$46.81 ▼ $87.62	$71.02B	1.29	7.89 million shs	2.95 million shs
GMM Global Mofy AI	$1.17 -0.8%	$1.31	$0.94 ▼ $3.29	$34.60M	-1.7	134,799 shs	73,358 shs
PFE Pfizer	$25.65 -3.1%	$27.14	$21.97 ▼ $28.75	$146.17B	0.35	42.90 million shs	37.25 million shs
QDEL QuidelOrtho	$10.80 +0.3%	$16.15	$10.21 ▼ $38.99	$735.48M	0.75	1.83 million shs	2.15 million shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABT Abbott Laboratories	+0.79%	-4.20%	-14.58%	-21.58%	-35.06%
GM General Motors	-0.26%	+1.94%	+8.06%	-6.92%	+72.50%
GMM Global Mofy AI	-5.60%	-7.09%	-15.71%	+4.42%	-47.56%
PFE Pfizer	-0.12%	-1.00%	-2.28%	-2.80%	+16.24%
QDEL QuidelOrtho	-1.73%	-12.44%	-28.10%	-62.99%	-58.34%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABT Abbott Laboratories	2.88	Moderate Buy	$119.43	41.79% Upside
GM General Motors	2.78	Moderate Buy	$94.65	20.16% Upside
GMM Global Mofy AI	1.00	Sell	N/A	N/A
PFE Pfizer	2.23	Hold	$28.74	12.05% Upside
QDEL QuidelOrtho	1.50	Reduce	$14.88	37.73% Upside

Current Analyst Ratings Breakdown

Latest ABT, GMM, GM, PFE, and QDEL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/7/2026	QDEL QuidelOrtho	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral	$12.00
5/7/2026	QDEL QuidelOrtho	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold	$35.00 ➝ $12.50
5/6/2026	PFE Pfizer	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)
5/6/2026	QDEL QuidelOrtho	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$30.00 ➝ $13.00
5/4/2026	GMM Global Mofy AI	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D-) ➝ Sell (D)
5/4/2026	GM General Motors	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform	$100.00
4/29/2026	GM General Motors	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$122.00 ➝ $126.00
4/29/2026	GM General Motors	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$102.00
4/29/2026	GM General Motors	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Outperform	$96.00 ➝ $95.00
4/29/2026	GM General Motors	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Underweight	$57.00 ➝ $59.00
4/29/2026	PFE Pfizer	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$26.00 ➝ $27.00

(Data available from 5/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABT Abbott Laboratories	$44.33B	3.31	$6.82 per share	12.35	$30.26 per share	2.78
GM General Motors	$184.62B	0.38	$27.07 per share	2.91	$71.75 per share	1.10
GMM Global Mofy AI	$55.94M	0.62	N/A	N/A	$2.10 per share	0.56
PFE Pfizer	$62.58B	2.34	$4.25 per share	6.03	$15.86 per share	1.62
QDEL QuidelOrtho	$2.73B	0.27	$18.62 per share	0.58	$27.19 per share	0.40

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABT Abbott Laboratories	$6.52B	$3.57	23.60	13.90	1.44	13.90%	17.62%	10.01%	7/16/2026 (Estimated)
GM General Motors	$2.70B	$2.48	31.76	5.59	0.40	1.38%	16.68%	3.87%	7/21/2026 (Estimated)
GMM Global Mofy AI	-$19.30M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PFE Pfizer	$7.77B	$1.31	19.58	8.97	N/A	11.83%	19.44%	8.41%	N/A
QDEL QuidelOrtho	-$1.13B	-$17.82	N/A	4.54	N/A	-45.57%	4.25%	1.56%	N/A

Latest ABT, GMM, GM, PFE, and QDEL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/5/2026	Q1 2026	PFE Pfizer	$0.7220	$0.75	+$0.0280	$0.47	$13.84 billion	$14.45 billion
5/5/2026	Q1 2026	QDEL QuidelOrtho	$0.37	-$0.04	-$0.41	-$1.35	$665.23 million	$619.80 million
4/28/2026	Q1 2026	GM General Motors	$2.61	$3.70	+$1.09	$2.82	$43.51 billion	$43.62 billion
4/16/2026	Q1 2026	ABT Abbott Laboratories	$1.14	$1.15	+$0.01	$0.61	$10.99 billion	$11.16 billion
2/11/2026	Q4 2025	QDEL QuidelOrtho	$0.43	$0.46	+$0.03	-$1.92	$699.80 million	$723.60 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABT Abbott Laboratories	$2.52	2.99%	+10.39%	70.59%	54 Years
GM General Motors	$0.72	0.91%	+8.45%	29.03%	3 Years
GMM Global Mofy AI	N/A	N/A	N/A	N/A	N/A
PFE Pfizer	$1.72	6.71%	-13.20%	131.30%	16 Years
QDEL QuidelOrtho	N/A	N/A	N/A	N/A	N/A

Latest ABT, GMM, GM, PFE, and QDEL Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/27/2026	GM General Motors	quarterly	$0.18	0.91%	6/5/2026	6/5/2026	6/18/2026
4/22/2026	PFE Pfizer	quarterly	$0.43	6.71%	5/8/2026	5/8/2026	6/12/2026
2/20/2026	ABT Abbott Laboratories	quarterly	$0.63	2.48%	4/15/2026	4/15/2026	5/15/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABT Abbott Laboratories	0.56	1.39	1.01
GM General Motors	1.41	1.15	0.99
GMM Global Mofy AI	N/A	1.10	1.10
PFE Pfizer	0.67	1.25	0.87
QDEL QuidelOrtho	1.33	1.43	0.90

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ABT Abbott Laboratories	75.18%
GM General Motors	92.67%
GMM Global Mofy AI	2.48%
PFE Pfizer	68.36%
QDEL QuidelOrtho	99.00%

Insider Ownership

Company	Insider Ownership
ABT Abbott Laboratories	0.46%
GM General Motors	0.54%
GMM Global Mofy AI	N/A
PFE Pfizer	0.62%
QDEL QuidelOrtho	0.79%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ABT Abbott Laboratories	115,000	1.74 billion	1.73 billion	Optionable
GM General Motors	156,000	901.67 million	896.80 million	Optionable
GMM Global Mofy AI	38	29.57 million	N/A	Not Optionable
PFE Pfizer	75,000	5.70 billion	5.65 billion	Optionable
QDEL QuidelOrtho	6,500	68.10 million	67.56 million	Optionable

ABT, GMM, GM, PFE, and QDEL Headlines

Recent News About These Companies

QuidelOrtho (NASDAQ:QDEL) Price Target Cut to $13.00 by Analysts at Citigroup

May 7 at 4:20 AM | americanbankingnews.com

QuidelOrtho Balances Near-Term Strain With Recovery Plan

May 6 at 9:11 PM | tipranks.com

Citigroup Has Lowered Expectations for QuidelOrtho (NASDAQ:QDEL) Stock Price

May 6 at 4:06 PM | marketbeat.com

QDEL Stock Down as Q1 Earnings Miss Estimates, Revenues Down Y/Y

May 6 at 1:21 PM | zacks.com

QuidelOrtho (NASDAQ:QDEL) Hits New 12-Month Low After Earnings Miss

May 6 at 10:21 AM | marketbeat.com

QuidelOrtho Corporation (NASDAQ:QDEL) Q1 2026 Earnings Call Transcript

May 6 at 9:58 AM | insidermonkey.com

QuidelOrtho (QDEL) Q1 2026 Earnings Transcript

May 6 at 9:58 AM | fool.com

QuidelOrtho (NASDAQ:QDEL) Misses Q1 CY2026 Revenue Estimates

May 6 at 9:58 AM | finance.yahoo.com

QuidelOrtho Corporation (QDEL) Q1 2026 Earnings Call Transcript

May 6 at 6:01 AM | seekingalpha.com

QuidelOrtho Q1 Earnings Call Highlights

May 5 at 10:06 PM | marketbeat.com

QuidelOrtho (NASDAQ:QDEL) Issues Earnings Results, Misses Expectations By $0.41 EPS

May 5 at 7:21 PM | marketbeat.com

QuidelOrtho (QDEL) Reports Q1 Loss, Tops Revenue Estimates

May 5 at 7:10 PM | zacks.com

QuidelOrtho (NASDAQ:QDEL) Issues FY 2026 Earnings Guidance

May 5 at 5:23 PM | marketbeat.com

QuidelOrtho Reports First Quarter 2026 Financial Results

May 5 at 4:05 PM | prnewswire.com

QuidelOrtho (QDEL) To Report Earnings Tomorrow: Here Is What To Expect

May 4, 2026 | finance.yahoo.com

QuidelOrtho (QDEL) to Release Quarterly Earnings on Tuesday

May 3, 2026 | americanbankingnews.com

QuidelOrtho (QDEL) price target decreased by 18.10% to 29.38

April 29, 2026 | msn.com

Analysts Estimate Perrigo (PRGO) to Report a Decline in Earnings: What to Look Out for

April 29, 2026 | zacks.com

QuidelOrtho (QDEL) Expected to Announce Quarterly Earnings on Tuesday

April 28, 2026 | marketbeat.com

Earnings Preview: QuidelOrtho (QDEL) Q1 Earnings Expected to Decline

April 28, 2026 | zacks.com

QuidelOrtho (NASDAQ:QDEL) Reaches New 12-Month Low - What's Next?

April 23, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

ABT, GMM, GM, PFE, and QDEL Company Descriptions

Abbott Laboratories NYSE:ABT

$84.24 -2.78 (-3.19%)

Closing price 03:59 PM Eastern

Extended Trading

$84.15 -0.08 (-0.10%)

As of 04:47 PM Eastern

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

General Motors NYSE:GM

$78.77 +0.36 (+0.46%)

Closing price 03:59 PM Eastern

Extended Trading

$78.33 -0.44 (-0.56%)

As of 04:47 PM Eastern

General Motors Company designs, builds, and sells trucks, crossovers, cars, and automobile parts; and provide software-enabled services and subscriptions worldwide. The company operates through GM North America, GM International, Cruise, and GM Financial segments. It markets its vehicles primarily under the Buick, Cadillac, Chevrolet, GMC, Baojun, and Wuling brand names. In addition, the company sells trucks, crossovers, cars, and automobile parts through retail dealers, and distributors and dealers, as well as to fleet customers, including daily rental car companies, commercial fleet customers, leasing companies, and governments. Further, it offers range of after-sale services through dealer network, such as maintenance, light repairs, collision repairs, vehicle accessories, and extended service warranties. Additionally, the company provides automotive financing; and software-enabled services and subscriptions. General Motors Company was founded in 1908 and is headquartered in Detroit, Michigan.

Global Mofy AI NASDAQ:GMM

$1.17 -0.01 (-0.85%)

Closing price 04:00 PM Eastern

Extended Trading

$1.17 0.00 (0.00%)

As of 04:36 PM Eastern

Global Mofy Metaverse Limited, through its subsidiaries, provides virtual content production, digital marketing, and digital assets development services for the metaverse industry in the People's Republic of China. It offers services for visual effect design, content development, production, and integration based on customers specific needs; and 3D rebuilt and artificial intelligence technologies using its Mofy Lab technology platform. The company also grants use right of digital assets for various applications, such as movies, TV series, AR/VR, animation, advertising, and gaming. Global The company was incorporated in 2021 and is headquartered in Beijing, the People's Republic of China.

Pfizer NYSE:PFE

$25.65 -0.83 (-3.15%)

Closing price 03:59 PM Eastern

Extended Trading

$25.65 +0.01 (+0.02%)

As of 04:47 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

QuidelOrtho NASDAQ:QDEL

$10.80 +0.03 (+0.28%)

Closing price 03:59 PM Eastern

Extended Trading

$10.94 +0.14 (+1.25%)

As of 04:22 PM Eastern

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ABT, GMM, GM, PFE, and QDEL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ABT, GMM, GM, PFE, and QDEL Earnings

Compare Dividends

Latest ABT, GMM, GM, PFE, and QDEL Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ABT, GMM, GM, PFE, and QDEL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ABT, GMM, GM, PFE, and QDEL Company Descriptions

Abbott Laboratories NYSE:ABT

General Motors NYSE:GM

Global Mofy AI NASDAQ:GMM

Pfizer NYSE:PFE

QuidelOrtho NASDAQ:QDEL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools